Feldman Igor - merck co | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 76 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Mrna-4157 (V940) Individualized Neoantigen Therapy (INT) Plus Pembrolizumab (pembro) in Advanced Unresectable HPV- Head & Neck Carcinoma (HNSCC): Clinical & Translational Analysis

Julie E. Bauman,Ricklie A. Julian,Jessica L. Geiger,Janice M. Mehnert,Jeffrey M. Clarke,Manish R. Patel,Martin Gutierrez,Justin F. Gainor,Shyam Srivats, Zhaojie Zhang, Anjali Rao,Vasudha Sehgal,Peijie Hou,Manju Morrissey,Igor Feldman,Lakshmi Srinivasan,Praveen Aanur,Michelle Brown,Robert S. Meehan

CANCER RESEARCHno. 7 (2024)

Cited0Views0Bibtex

Preclinical Efficacy of VTX-0811: A Humanized First-in-Class PSGL-1 Mab Targeting TAMs to Suppress Tumor Growth

Tatiana Novobrantseva,Denise Manfra,Jessica Ritter, Maja Razlog,Brian O'Nuallain,Mohammad Zafari,Dominika Nowakowska,Sara Basinski, Ryan T. Phennicie,Phuong A. Nguyen,Michael A. Brehm,Stephen Sazinsky,Igor Feldman

Cancersno. 16 (2024): 2778-2778

Cited0Views0WOSBibtex

Antibodies Targeting Human or Mouse VSIG4 Repolarize Tumor-Associated Macrophages Providing the Potential of Potent and Specific Clinical Anti-Tumor Response Induced Across Multiple Cancer Types

Stephen Sazinsky,Mohammad Zafari,Boris Klebanov,Jessica Ritter,Phuong A. Nguyen, Ryan T. Phennicie,Joe Wahle,Kevin J. Kauffman, Maja Razlog,Denise Manfra,Igor Feldman,Tatiana Novobrantseva

International Journal of Molecular Sciencesno. 11 (2024): 6160-6160

Cited3Views0WOSBibtex

Abstract CT141: Mrna-4157 (V940) Individualized Neoantigen Therapy (INT) + Pembrolizumab (pembro) in Advanced Unresectable HPV- Head & Neck Carcinoma (HNSCC): Clinical & Translational Analysis

Cancer Researchno. 7_Supplement (2024)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn